Indeed a role for RBP4 in the catabolism of very low-density lipoprotein (VLDL) [14] and the formation of sdLDL has been suggested [17], [18], though the implication of RBP4 in components of atherogenic dyslipidemia has been studied very little. The gene discussed is RBP4; the disease is metabolic syndrome.